EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE

被引：0

作者：

Markova, J. ^{[1
]}

Kobe, C. ^{[2
]}

Skopalova, M. ^{[3
]}

Zikavska, L. ^{[1
]}

Vernerova, Z. ^{[1
]}

Klaskova, K. ^{[1
]}

Dedeckova, K. ^{[4
]}

Eich, H. T. ^{[5
]}

Dietlein, M. ^{[2
]}

Fuchs, M. ^{[6
]}

Engert, A. ^{[7
]}

Kozak, T. ^{[1
]}

机构：

[1] Univ Hosp Kralovske Vinohrady, Prague 0, Czech Republic

[2] Univ Cologne, Dept Nucl Med, D-50924 Cologne, Germany

[3] Na Homolce Hosp, PET Ctr, Dept Nucl Med, Prague, Czech Republic

[4] Univ Hosp Na Bulovce, Inst Radiat Oncol, Prague 8, Czech Republic

[5] Univ Cologne, Dept Radiat Oncol, D-50924 Cologne, Germany

[6] Univ Cologne, German Hodgkin Study Grp, D-50924 Cologne, Germany

[7] Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0084

引用

页码：33 / 33

页数：1

共 50 条

[1] FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
Markova, J.
Kobe, C.
Skopalova, M.
Klaskova, K.
Dedeckova, K.
Plutschow, A.
Eich, H. T.
Dietlein, M.
Engert, A.
Kozak, T.
ANNALS OF ONCOLOGY, 2009, 20 (07) : 1270 - 1274
[2] RESPONSE ASSESSMENT AFTER 4 CYCLES OF BEACOPP USING FDG-PET IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA
Markova, J.
Kobe, C.
Skopalova, M.
Dedeckova, K.
Mocikova, H.
Klaskova, K.
Kahraman, D.
Dietlein, M.
Kozak, T.
ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
[3] Response assessment after 4 cycles of beacopp using FDG-PET in patients with advanced-stage hodgkin lymphoma
Markova, J.
Kahraman, T. D.
Kobe, C.
Skopalova, M.
Dedeckova, K.
Gaherova, L.
Dietlein, M.
Kozak, T.
ONKOLOGIE, 2011, 34 : 132 - 132
[4] Assessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
Kobe, C.
Markova, J.
Skopalova, M.
Klaskova, K.
Dedeckova, K.
Pluetschow, A.
Eich, H. T.
Dietlein, M.
Engert, A.
Kozak, T.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S252 - S253
[5] eAssessment of Early Treatment Response after 4 Cycles of Chemotherapy using FDG-PET in Patients with Advanced-Stage Hodgkin Lymphoma
Kobe, C.
Markova, J.
Skopalova, M.
Klaskova, K.
Dedeckova, K.
Pluetschow, A.
Eich, H. T.
Dietlein, M.
Engert, A.
Kozak, T.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 252 - 253
[6] Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
Adams, Hugo J. A.
Kwee, Thomas C.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 758 - 760
[7] FDG-PET for assessment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma
Markova, J.
Skopalova, M.
Kobe, C.
Klaskova, K.
Zikavska, L.
Polivka, J.
Vernerova, Z.
Kamaradova, K.
Dedeckova, K.
Kozak, T.
ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
[8] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
Adams, Hugo J. A.
Kwee, Thomas C.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
[9] Early FDG-PET scan in advanced stage Hodgkin lymphoma treated with BEACOPP-14
Rubio-Martinez, A.
Alvarez, R.
Garcia-Miralles, M.
Gaston, R.
Giraldo, P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 471 - 472
[10] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
Adams, Hugo J. A.
Kwee, Thomas C.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 129 - 131

← 1 2 3 4 5 →